A development stage biopharmaceutical corporation which is engaged in the discovery and development of prescription pain management products.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
I just closed an underperform on Adolor and I'm ready to turn it around. While Entereg may not be a gangbuster success it's got a lot of potential. In every hospital in this country there's a ward of post-op patients getting their bellies tapped and listened to waiting for their guts to wake up so they can get fed and kicked out the door. Every surgeon would love to speed up that process and lower their hospital stay stats. I didn't think Enetereg would get approved, but now that it is I'm going to put my CAPS bet on it and start looking for the numbers next quarter.
I'm still positive on Adolor and Entereg, just resetting my outperform at a lower price. Thanks S&P!